Dr. Coleman on Findings from the AZURE Trial for Breast Cancer Treatment

Описание к видео Dr. Coleman on Findings from the AZURE Trial for Breast Cancer Treatment

Robert E. Coleman, MBBS, MD, FRCP, FRCPE, professor of Medical Oncology and head of the Academic Unit of Clinical Oncology at the University of Sheffield, discusses the safety findings from the 10-year follow-up of the adjuvant treatment with zoledronic acid (ZOL) in stage II/III breast cancer, which was studied in the AZURE trial.

Комментарии

Информация по комментариям в разработке